News
A separate Prime analysis, however, of year-over-year claims data for Wegovy and Zepbound only found an improvement in ...
As Ohio cuts off state employees' coverage of medications for weight loss, a lawmaker who has benefited from the drugs wants to bring them back.
Uninsured or self-pay obesity patients can get any dose of Wegovy for $299 from July 1–31, 2025. Patients can get their ...
Gov. Jeff Landry struck language from the Louisiana budget plan that could have provided state employees and public school teachers with insurance coverage for popular weight-loss medication over the ...
Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.
Dive Insight: Though Novo is a pioneer in the development of in-demand obesity medicines, it currently finds itself on the defensive.Zepbound’s fast launch has eroded Wegovy’s market share, and Novo’s ...
Cigna Healthcare, the health benefits division of the Cigna Group, has released a set of digital tools aimed at improving the ...
Novo Nordisk’s drugs are being linked to an eye condition that can cause vision loss, while health tech companies made CNBC’s Disruptor 50 List.
By Amina Niasse (Reuters) -Hims & Hers Health is betting that the cash-pay market for weight-loss drugs will drive up customer demand although some analysts see a need for the online website to adjust ...
Hims & Hers Health is betting that the cash-pay market for weight-loss drugs will drive up customer demand although some analysts see a need for the online website to adjust to changing competition in ...
(Reuters) -Hims & Hers Health is betting that the cash-pay market for weight-loss drugs will drive up customer demand although some analysts see a need for the online website to adjust to changing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results